Praxis Precision Medicines (PRAX)
(Delayed Data from NSDQ)
$42.22 USD
-3.01 (-6.65%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $42.70 +0.48 (1.14%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Praxis Precision Medicines, Inc. has a market cap of $952.07M, which represents its share price of $45.23 multiplied by its outstanding shares number of 21.05M. As a small-cap company, PRAX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PRAX 42.22 -3.01(-6.65%)
Will PRAX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PRAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRAX
Praxis Precision Medicines, Inc. (PRAX) Reports Q4 Loss, Tops Revenue Estimates
IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
PRAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Ensign Group (ENSG) Q4 Earnings and Revenues Beat Estimates
Praxis Precision Medicines, Inc. (PRAX) Reports Q3 Loss, Misses Revenue Estimates
Other News for PRAX
PRAX Fell Below 20 Day Moving Average on September 19
Crossed Above 20 Day Moving Average appears for PRAX after 2.73% move
Is PRAX ready to move higher? Directional Movement Crossover Bullish shows up after climbing 4.83%
PRAX Coverage Initiated by Jones Trading with Buy Rating | PRAX Stock News
H.C. Wainwright Remains a Buy on Praxis Precision Medicines (PRAX)